Biohaven's Q3 update: FDA accepts Vyglxia filing, SK Biopharmaceuticals deal pendingOct 29Quarterly updateBiohaven Ltd.
FDA places partial clinical hold on Biohaven's BHV-7000 epilepsy programSep 9Regulatory milestoneBHV-7000Biohaven Ltd.
Biohaven files license and assignment agreements for SK Biopharmaceuticals Kv7 dealAug 26PartnershipBiohaven Ltd.